enGene Therapeutics, Inc. (ENGN)
1.80
+0.03
(+1.69%)
USD |
NASDAQ |
Sep 11, 16:00
1.79
-0.01
(-0.56%)
After-Hours: 06:47
enGene Therapeutics EPS Diluted (Quarterly) : -0.4661 for July 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.4661 |
| April 30, 2026 | -0.4335 |
| January 31, 2026 | -0.4423 |
| October 31, 2025 | -0.7383 |
| July 31, 2025 | -0.5674 |
| April 30, 2025 | -0.506 |
| January 31, 2025 | -0.4829 |
| October 31, 2024 | -0.3392 |
| July 31, 2024 | -0.3203 |
| April 30, 2024 | -0.3799 |
| January 31, 2024 | -0.4617 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.0497 |
| July 31, 2023 | -0.0031 |
| June 30, 2023 | -0.1713 |
| March 31, 2023 | -0.0223 |
| December 31, 2022 | 0.0392 |
| September 30, 2022 | 0.0046 |
| June 30, 2022 | -0.0163 |
| March 31, 2022 | -0.0255 |
| December 31, 2021 | -0.0136 |
| September 30, 2021 | -0.0007 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.2802 |
| Medicus Pharma Ltd. | -0.1524 |
| Xenon Pharmaceuticals, Inc. | -1.112 |
| Psyence Biomedical Ltd. | -3.178 |
| Geron Corp. | -0.0249 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.50M |
| Total Expenses (Quarterly) | 32.50M |
| Enterprise Value | -112.50M |
| Earnings Yield | -115.6% |
| Normalized Earnings Yield | -115.29 |